Prime Capital Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,716
Closed -$328K 994
2023
Q4
$328K Buy
+1,716
New +$328K 0.01% 709